User profiles for Sharyle Fowler
 | Sharyle FowlerAssistant Professor, University of Saskatchewan Verified email at usask.ca Cited by 1296 |
The Toronto consensus statements for the management of inflammatory bowel disease in pregnancy
…, CJ Van Der Woude, A Bitton, B Bressler, S Fowler… - Gastroenterology, 2016 - Elsevier
Background & Aims The management of inflammatory bowel disease (IBD) poses a particular
challenge during pregnancy because the health of both the mother and the fetus must be …
challenge during pregnancy because the health of both the mother and the fetus must be …
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3 …
…, A Fischer, A Fixelle, M Fleisher, S Fowler… - The lancet …, 2022 - thelancet.com
Background Etrolizumab is a gut-targeted, anti-β7 integrin, monoclonal antibody. In an earlier
phase 2 induction study, etrolizumab significantly improved clinical remission compared …
phase 2 induction study, etrolizumab significantly improved clinical remission compared …
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 …
Background Etrolizumab is a gut-targeted anti-β7 integrin monoclonal antibody. In a previous
phase 2 induction study, etrolizumab significantly improved clinical remission versus …
phase 2 induction study, etrolizumab significantly improved clinical remission versus …
[HTML][HTML] Non-pharmacological therapies for inflammatory bowel disease: Recommendations for self-care and physician guidance
We performed a scoping review on sought-after complementary therapies for patients with
inflammatory bowel disease (IBD), specifically diet, physical activity and exercise (PA/E), and …
inflammatory bowel disease (IBD), specifically diet, physical activity and exercise (PA/E), and …
Increasing prevalence and stable incidence rates of inflammatory bowel disease among first nations: population-based evidence from a western Canadian province
Background There is limited to no evidence of the prevalence and incidence rates of
inflammatory bowel disease (IBD) among Indigenous peoples. In partnership with Indigenous …
inflammatory bowel disease (IBD) among Indigenous peoples. In partnership with Indigenous …
Effects of cancer treatment on inflammatory bowel disease remission and reactivation
BACKGROUND & AIMS: Little is known about the effects of cancer therapy for extraintestinal
malignancy in patients with inflammatory bowel diseases (IBDs). METHODS: We analyzed …
malignancy in patients with inflammatory bowel diseases (IBDs). METHODS: We analyzed …
Development of a screening tool to detect nutrition risk in patients with inflammatory bowel disease
…, JL Jones, SA Fowler - Asia Pacific journal of …, 2018 - search.informit.org
Background and Objectives: Malnutrition is a known complication of Inflammatory Bowel
Disease (IBD). We assessed a known screening tool, as well as developed and validated a …
Disease (IBD). We assessed a known screening tool, as well as developed and validated a …
SMAD3 gene variant is a risk factor for recurrent surgery in patients with Crohn's disease
SA Fowler, AN Ananthakrishnan… - Journal of Crohn's …, 2014 - academic.oup.com
Background and aims More than 80% of Crohn's disease (CD) patients will require surgery.
Surgery is not curative and rates of re-operation are high. Identification of genetic variants …
Surgery is not curative and rates of re-operation are high. Identification of genetic variants …
Impact of an integrated model of care on outcomes of patients with inflammatory bowel diseases: Evidence from a population-based study
Background and Aims Studies evaluating the impact of integrated models of care [IMC] for
inflammatory bowel disease [IBD] on disease-related outcomes are needed. We compared …
inflammatory bowel disease [IBD] on disease-related outcomes are needed. We compared …
Elevation of serum pyruvate kinase M2 (PKM2) in IBD and its relationship to IBD indices
Objectives Endoscopy remains the gold standard to diagnose and evaluate inflammatory
bowel disease (IBD) activity. Current biomarkers or their combinations cannot adequately …
bowel disease (IBD) activity. Current biomarkers or their combinations cannot adequately …
